Efficacy and safety of regorafenib compared to placebo and to post-cross-over regorafenib in advanced non-adipocytic soft tissue sarcoma

Christine Desmedt; Roberto Salgado; Marco Fornili; Giancarlo Pruneri; Gert van den Eynden; Gabriele Zoppoli; Françoise Rothé; Laurence Buisseret; Soizic Garaud; Karen Willard-Gallo; David Brown; Yacine Bareche; Ghizlane Rouas; Christine Galant; Sherene Loi; Giuseppe Viale; Angelo Di Leo; Andrew Green; Ian Ellis; Emad Rakha; Denis Larsimont; Elia Biganzoli; Christos Sotiriou; Thomas Brodowicz; Olivier Mir; Jennifer Wallet; Antoine Italiano; Jean-Yves Blay; François Bertucci; Wolfgang Eisterer; Christine Chevreau; Sophie Piperno-Neumann; Emmanuelle Bompas; Thomas Ryckewaert; Bernadette Liegl-Antzwager; Julien Thery; Nicolas Penel; Axel Le Cesne; Marie-Cécile Le Deley

doi:10.1016/j.ejca.2018.05.008

Back

Efficacy and safety of regorafenib compared to placebo and to post-cross-over regorafenib in advanced non-adipocytic soft tissue sarcoma

Journal article

Peer reviewed

Efficacy and safety of regorafenib compared to placebo and to post-cross-over regorafenib in advanced non-adipocytic soft tissue sarcoma

Christine Desmedt, Roberto Salgado, Marco Fornili, Giancarlo Pruneri, Gert van den Eynden, Gabriele Zoppoli, Françoise Rothé, Laurence Buisseret, Soizic Garaud, Karen Willard-Gallo, …

European Journal of Cancer, Vol.99(7), pp.28-36

08/2018

DOI: https://doi.org/10.1016/j.ejca.2018.05.008

Files and links (1)

url

Find in HALView

Metrics

1 Record Views

Details

Title: Efficacy and safety of regorafenib compared to placebo and to post-cross-over regorafenib in advanced non-adipocytic soft tissue sarcoma
Creators - without role: Christine Desmedt - Breast Cancer Research Foundation
Roberto Salgado - Breast Cancer Research Foundation
Marco Fornili - University of Pisa
Giancarlo Pruneri - European Institute of Oncology
Gert van den Eynden
Gabriele Zoppoli - Ospedale Policlinico San Martino
Françoise Rothé
Laurence Buisseret
Soizic Garaud - Bipar
Karen Willard-Gallo - Institut Jules Bordet
David Brown - Institut des Matériaux Jean Rouxel
Yacine Bareche - Université de Montpellier, Institut de Génétique Moléculaire de Montpellier - IGMM
Ghizlane Rouas - Institut Jules Bordet
Christine Galant - Cliniques Universitaires Saint-Luc
Sherene Loi - Breast Cancer Research Foundation
Giuseppe Viale - Division of Pathology and Laboratory Medicine
Angelo Di Leo - Hospital of Prato
Andrew Green - Centre for Biomedical Network Research on Rare Diseases
Ian Ellis
Emad Rakha
Denis Larsimont
Elia Biganzoli
Christos Sotiriou
Thomas Brodowicz - Université médicale de Vienne, Autriche
Olivier Mir - Sarcome
Jennifer Wallet - Centre Hospitalier Universitaire de Lille
Antoine Italiano - Institut Bergonié
Jean-Yves Blay - Centre Léon Bérard
François Bertucci - Centre de Recherche en Cancérologie de Marseille
Wolfgang Eisterer
Christine Chevreau - Institut universitaire du cancer de Toulouse Oncopole
Sophie Piperno-Neumann - Institut Curie
Emmanuelle Bompas - Institut Génétique Nantes Atlantique
Thomas Ryckewaert - Département d'oncologie médicale
Bernadette Liegl-Antzwager
Julien Thery
Nicolas Penel - Université de Lille
Axel Le Cesne - Sarcome
Marie-Cécile Le Deley
Publication Details: European Journal of Cancer, Vol.99(7), pp.28-36
Identifiers: 9934588009311
Academic Unit: Institut de Génétique Moléculaire de Montpellier - IGMM
Language: English
Resource Type: Journal article
Local Fields: hal-03623702